Literature DB >> 8320402

Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. The DCCT Research Group.

E J Anderson1, M Richardson, G Castle, S Cercone, L Delahanty, R Lyon, D Mueller, L Snetselaar.   

Abstract

As part of an intensive treatment regimen that had as its goal achieving and maintaining blood glucose levels in the normal range in individuals with insulin-dependent diabetes mellitus, dietitians in the Diabetes Control and Complications Trial implemented varying nutrition intervention strategies to counsel patients to attain normoglycemia. Dietary management encompassed recommendations on altering insulin dosages for varying food intake. Nutrition intervention was tailored to best meet a participant's life-style, motivation, ability to grasp information, diet history, and specific intensive insulin therapy. Dietitians were integral participants in the team management of individuals in the intensive treatment group. Selected nutrition interventions--Healthy Food Choices, exchange systems, carbohydrate counting, and total available glucose--and behavior management approaches were coupled with intensive insulin therapy. Case presentations illustrate each nutrition intervention in the attainment of normoglycemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320402     DOI: 10.1016/0002-8223(93)91750-k

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  24 in total

1.  Intensive dietary intervention by a dietitian as a case manager among community dwelling older adults: the EDIT study.

Authors:  R Endevelt; J Lemberger; J Bregman; G Kowen; I Berger-Fecht; H Lander; T Karpati; D R Shahar
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

2.  Adjusting mealtime insulin based on meal carbohydrate content improves glycemic control and quality of life.

Authors:  Marion J Franz
Journal:  Curr Diab Rep       Date:  2003-10       Impact factor: 4.810

3.  Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Authors:  Jonathan Q Purnell; Barbara H Braffett; Bernard Zinman; Rose A Gubitosi-Klug; William Sivitz; John P Bantle; Georgia Ziegler; Patricia A Cleary; John D Brunzell
Journal:  Diabetes Care       Date:  2017-12       Impact factor: 19.112

4.  Accurate Carbohydrate Counting Is an Important Determinant of Postprandial Glycemia in Children and Adolescents With Type 1 Diabetes on Insulin Pump Therapy.

Authors:  Asma Deeb; Ahlam Al Hajeri; Iman Alhmoudi; Nico Nagelkerke
Journal:  J Diabetes Sci Technol       Date:  2016-11-21

Review 5.  Carbohydrate and diabetes: is the source or the amount of more importance?

Authors:  M J Franz
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

Review 6.  New aspects of insulin therapy in type 1 and type 2 diabetes.

Authors:  D G Dills
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

7.  Cardiovascular disease and glycemic treatment.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-11       Impact factor: 19.112

8.  Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus.

Authors:  T R Nansel; L M Lipsky; R J Iannotti
Journal:  Diabetes Res Clin Pract       Date:  2013-01-20       Impact factor: 5.602

9.  Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial.

Authors:  Linda M Delahanty; David M Nathan; John M Lachin; Frank B Hu; Patricia A Cleary; Georgia K Ziegler; Judith Wylie-Rosett; Deborah J Wexler
Journal:  Am J Clin Nutr       Date:  2008-12-23       Impact factor: 7.045

Review 10.  Intensive diabetes management in pediatric patients.

Authors:  B Buckingham; B Bluck; D M Wilson
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.